We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Effect of Remote Ischemia Preconditioning on Myocardial Injury in Patients Undergoing Heart Valve Surgery

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01175681
Recruitment Status : Completed
First Posted : August 5, 2010
Last Update Posted : July 21, 2011
Guangzhou First People's Hospital
Information provided by:
Sun Yat-sen University

Brief Summary:
Remote ischaemic preconditioning has shown its cardiac protective effect during heart surgery including coronary artery bypass graft surgery, congenital heart disease and aneurysm. However, no data was reported on heart valve disease surgery. Rheumatic heart disease is one of the major heart diseases requiring surgery in China. Thus, the investigators chose heart valve disease as a focus to see whether remote ischaemic preconditioning also has cardiac protective effect during heart valve surgery.

Condition or disease Intervention/treatment
Heart Valve Diseases Procedure: remote ischaemic preconditioning

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 73 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Outcomes Assessor)
Primary Purpose: Prevention
Official Title: Effect of Remote Ischemia Preconditioning on Myocardial Injury in Patients Undergoing Heart Valve Surgery
Study Start Date : December 2007
Primary Completion Date : March 2011
Study Completion Date : June 2011

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Arm Intervention/treatment
Experimental: treatment
remote ischaemic preconditioning
Procedure: remote ischaemic preconditioning
Remote ischaemic preconditioning consisted of three 5-min cycles of right upper arm ischaemia, which was induced by an automated cuff -inflator placed on the right upper arm and inflated to 200 mm Hg, with an intervening 5 min of reperfusion during which the cuff was deflated. There was a 5- to 10-min interval between completion of the remote ischaemic preconditioning protocol and initiation of bypass.Control patients had a deflated cuff placed on the right upper arm for 30 min.
No Intervention: untreated

Primary Outcome Measures :
  1. plasma troponin I level [ Time Frame: with 7 days after surgery ]
    The investigators will measure the plasma troponin I level in several time points before and after surgery in each patient.

Secondary Outcome Measures :
  1. serum creatinine [ Time Frame: within 7 days after surgery ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • All heart valve diseases needing heart valve surgery.

Exclusion Criteria:

  • All four limbs existed ischemic condition

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01175681

China, Guangdong
Guangzhou First Municipal People's Hospital
Guangzhou, Guangdong, China, 510180
Sponsors and Collaborators
Sun Yat-sen University
Guangzhou First People's Hospital
Principal Investigator: Jing-song Ou, MD,PhD The Frist Affiliated Hospital, Sun Yat-sen University

Additional Information:
Pubmed  This link exits the ClinicalTrials.gov site

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Jing-song Ou/ professor, The First Affiliated Hospital, Sun Yat-sen University.
ClinicalTrials.gov Identifier: NCT01175681     History of Changes
Other Study ID Numbers: ischemia
First Posted: August 5, 2010    Key Record Dates
Last Update Posted: July 21, 2011
Last Verified: July 2010

Keywords provided by Sun Yat-sen University:
rheumatic heart disease
degenerated heart valve disease
heart valve prolapse

Additional relevant MeSH terms:
Heart Valve Diseases
Pathologic Processes
Heart Diseases
Cardiovascular Diseases